Clinical Trial Update: Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating sunitinib in newly diagnosed stage II/III breast cancer that can be removed by surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Sunitinib (sunitinib)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED